EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake

Austin E Cantu, Cordelia Rasa, Shizue Mito iD, Denae Cantu, Juan Carlos Lopez-Alvarenga iD, Leslie L Rivera-Lopez, Israel Rios, Ashley Abrego-Gonzalez, Sara M Reyna iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Austin E Cantu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Houston, TX 76798, USA. Hauptthemen laut MEDLINE: Obesity, Oleanolic Acid, Hyperglycemia, Hyperinsulinism. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a significant factor in the development of type 2 diabetes (T2D). Treatment of obesity is pivotal in the prevention and management of T2D, and the development of new pharmacological therapies are studied for improving insulin resistance and glucose intolerance. Oleanolic acid-derived triterpenoids, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acids (CDDOs), are studied to elucidate the mechanisms by which they protect against obesity. However, fundamental knowledge gaps remain regarding the physiological and molecular mechanisms by which CDDOs protect against obesity. Our recently published studies showed that CDDO-ethyl amide (CDDO-EA) prevents skeletal muscle inflammation by inhibiting activation of nuclear factor-kappa B (NF-κB) signaling. Moreover, CDDO-EA induced translocation of glucose transporter 4, GLUT4, in skeletal muscle cells. We hypothesized that CDDO-EA protects from obesity-induced hyperglycemia in mice fed a high-fat diet (HFD). Our results show that CDDO-EA protects from HFD-induced obesity but has no effect on body weight in mice fed a low-fat diet (LFD). Our data show that CDDO-EA inhibition of weight gain is associated with reduced caloric intake and glucose and insulin levels in mice fed an HFD. This highlights the potential of CDDO-EA as a therapeutic agent for obesity treatment and the protection against the development of T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityOleanolic AcidHyperglycemiaHyperinsulinismEnergy IntakeAnimalsMiceDiet, High-FatMaleMuscle, SkeletalGlucose Transporter Type 4Insulin ResistanceDiabetes Mellitus, Type 2Mice, Inbred C57BLHumans

Stichwörter der Autor:innen

CDDO-EAinsulin resistancemouse modelobesitytype 2 diabetes

Substanzen

Oleanolic Acid2-cyano-3,12-dioxoolean-1,9-dien-28-oic acidGlucose Transporter Type 4

Autor:innen und Institutionen

  • Baylor College of Medicine, Houston, TX 76798, USA.
  • Department of Laboratory Animal Resources, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
  • Department of Medical Education, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78541, USA.
  • School of Podiatric Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
  • Division of Population Health and Biostatistics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
  • Department of Translational Sciences, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

ORCID-Profile: Shizue Mito, Juan Carlos Lopez-Alvarenga, Sara M Reyna

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • University of Texas Rio Grande Valley Faculty Research Seed Grant
  • Institutional Seed Research Program Award
  • Engaged Scholar and Artist Award

Zitieren

APA

Cantu, A. E., Rasa, C., Mito, S., Cantu, D., Lopez-Alvarenga, J. C., Rivera-Lopez, L. L., Rios, I., Abrego-Gonzalez, A., & Reyna, S. M. (2025). Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125485

Vancouver

Cantu AE, Rasa C, Mito S, Cantu D, Lopez-Alvarenga JC, Rivera-Lopez LL, et al. Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125485

BibTeX
@article{Cantu2025,
  author = {Cantu, Austin E and Rasa, Cordelia and Mito, Shizue and Cantu, Denae and Lopez-Alvarenga, Juan Carlos and Rivera-Lopez, Leslie L and Rios, Israel and Abrego-Gonzalez, Ashley and Reyna, Sara M},
  title = {Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125485}
}
Kostenlos starten →